Recurrent mutations in genes involved in nuclear factor‐κB signalling in nodal marginal zone lymphoma—diagnostic and therapeutic implications

To investigate the spectrum of mutations in 20 genes involved in B‐cell receptor and/or Toll‐like receptor signalling resulting in activation of nuclear factor‐κB (NF‐κB) in 20 nodal marginal zone lymphomas (NMZLs), 20 follicular lymphomas (FLs), and 11 cases of B‐cell lymphoma, unclassifiable (BCL‐u).

• Publication year

  2017

• Venue

  Histopathology

• Publication date

  2017-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/his.13015PMID 27297871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

  2015cited by this paper
• The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing

  2015cited by this paper
• Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma – combined performance of multiple markers

  2015influential reference
• Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

  2015influential reference
• The Coding Genome of Nodal Marginal Zone Lymphoma Reveals Recurrent Molecular Alterations of PTPRD and Other Jak/Stat Signaling Genes

  2014cited by this paper
• Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

  2013cited by this paper
• Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review

  2013cited by this paper
• Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review

  2013cited by this paper
• A20 inactivation in ocular adnexal MALT lymphoma

  2012cited by this paper
• The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

  2012cited by this paper
• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  2012cited by this paper
• High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis

  2012cited by this paper
• IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas

  2012cited by this paper
• Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

  2012influential reference
• TNFAIP3 abnormalities in MALT lymphoma with autoimmunity

  2011cited by this paper
• Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

  2011cited by this paper
• MALT lymphoma: many roads lead to nuclear factor‐κb activation

  2011cited by this paper
• A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma

  2010cited by this paper
• Cancer esearch cular and Cellular Pathobiology uired TNFRSF 14 Mutations in Follicular Lymphoma Are R ociated with Worse Prognosis

  2010cited by this paper
• A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.

  2009influential reference
• NF-kappaB as a critical link between inflammation and cancer.

  2009cited by this paper
• Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

  2009cited by this paper
• Identification of MNDA as a new marker for nodal marginal zone lymphoma

  2009cited by this paper
• TNFAIP3 is the target gene of chromosome band 6q23.3‐q24.1 loss in ocular adnexal marginal zone B cell lymphoma

  2008cited by this paper
• The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

  2008cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Phosphorylation of the CARMA1 linker controls NF-kappaB activation.

  2005cited by this paper
• Phosphorylation of the CARMA1 Linker Controls NF-κB Activation

  2005cited by this paper
• Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.

  2005cited by this paper
• Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

  2004cited by this paper
• Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

  2004cited by this paper
• The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

  2004cited by this paper
• Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).

  2003cited by this paper
• Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity

  2003cited by this paper
• Bimp1, a MAGUK Family Member Linking Protein Kinase C Activation to Bcl10-mediated NF-κB Induction*

  2001cited by this paper
• Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway*

  2001cited by this paper
• CARD11 and CARD14 Are Novel Caspase Recruitment Domain (CARD)/Membrane-associated Guanylate Kinase (MAGUK) Family Members that Interact with BCL10 and Activate NF-κB*

  2001cited by this paper
• Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation1

  2001cited by this paper

• Bridging Clinicopathologic Features and Genetics in Follicular Lymphoma: Towards Enhanced Diagnostic Accuracy and Subtype Differentiation.

  2024cites this paper
• Molecular Profiling of Small Mature B Cell Lymphomas; New Insights on Diagnosis and Treatment

  2024cites this paper
• Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2-/BCL6- Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma.

  2023cites this paper
• [WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors].

  2023cites this paper
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

  2022cites this paper
• Exploiting Tumor Necrosis Factor Aberrations in Marginal Zone Lymphoma.

  2021cites this paper
• Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation

  2021cites this paper
• Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin

  2021cites this paper
• CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma

  2020influential citation
• The complex pathology and differential diagnosis of splenic and nodal marginal zone lymphoma

  2020cites this paper
• Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B‐cell lymphoma

  2019cites this paper
• Nodal Marginal Zone Lymphoma

  2019cites this paper
• As the world turns, evolving lymphoma classifications - past, present and future.

  2019cites this paper
• High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations

  2018cites this paper
• Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas

  2018cites this paper
• Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation

  2018cites this paper
• Cytogenetic and molecular testing in lymphoma patients

  2018cites this paper
• Nodal Marginal Zone Lymphoma

  2018cites this paper
• Marginal zone lymphoma: Diagnostic challenges among different entities

  2018cites this paper
• New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017

  2017cites this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2017

  2017cites this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017

  2017cites this paper
• Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review

  2017cites this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from June–August 2016

  2016cites this paper